Oxcarbazepine API (CAS# 28721-07-05 ) is solid and used in anticonvulsant Industry. Oxcarbazepine is an anticonvulsant agent generally used in the treatment of partial seizures in children and adults with epilepsy. It is a structural derivative of carbamazepine, with an extra oxygen atom to the benzylcarboxamide group.
This report contains market size and forecasts of Oxcarbazepine API in global, including the following market information:
Global Oxcarbazepine API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oxcarbazepine API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Oxcarbazepine API companies in 2021 (%)
The global Oxcarbazepine API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medical Grade Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oxcarbazepine API include Sun Pharm, Jubilant Pharma, Zhejiang Jiuzhou Pharmaceutical, Amoli Organics, F.I.S.(Fabbrica Italiana Sintetici), Mylan, Glenmark, Bajaj Healthcare and Archimica, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oxcarbazepine API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oxcarbazepine API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Oxcarbazepine API Market Segment Percentages, by Type, 2021 (%)
Medical Grade
Other
Global Oxcarbazepine API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Oxcarbazepine API Market Segment Percentages, by Application, 2021 (%)
Tablets
Oral Suspension
Other
Global Oxcarbazepine API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Oxcarbazepine API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oxcarbazepine API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oxcarbazepine API revenues share in global market, 2021 (%)
Key companies Oxcarbazepine API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Oxcarbazepine API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sun Pharm
Jubilant Pharma
Zhejiang Jiuzhou Pharmaceutical
Amoli Organics
F.I.S.(Fabbrica Italiana Sintetici)
Mylan
Glenmark
Bajaj Healthcare
Archimica
POLPHARMA
Trifarma
Hubei Gedian Humanwell
Sihuan Pharm
CTX Life Sciences
VPL Chemicals
MSN Laboratories
Anuja Healthcare
Taj Pharmaceuticals
Lianhetech
Suzhou Hengyi Pharmaceutical
Aurore Life Sciences
DEAFARMA